Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;2(1):173-180.
doi: 10.2147/SAR.S24800.

Problematic Use of Prescription-Type Opioids Prior to Heroin Use Among Young Heroin Injectors

Affiliations
Free PMC article

Problematic Use of Prescription-Type Opioids Prior to Heroin Use Among Young Heroin Injectors

Robin A Pollini et al. Subst Abuse Rehabil. .
Free PMC article

Abstract

BACKGROUND: Misuse of prescription-type opioids and related adverse health effects are increasing, but little is known about the role of these drugs as a precursor to heroin use. We conducted an exploratory study to determine the proportion of young heroin injectors reporting problematic use of prescription-type opioids prior to using heroin, and to describe the factors associated with prior problematic prescription-type opioid use. METHODS: Between March 2009 and June 2010, we recruited injection drug users (IDUs) for a cross-sectional study of hepatitis C virus infection risk. Participants were aged 18-40 years and had injected illicit drugs within the previous six months. A computerized self-administered survey assessed sociodemographics, drug use history, human immunodeficiency virus (HIV)/hepatitis C virus risk behaviors and perceptions, and medical history. We added questions on prescription-type opioid use to the parent study in March 2010; heroin injectors who subsequently enrolled and reported problematic prescription-type opioid use prior to heroin initiation were compared with other heroin IDUs using univariate and multivariate regression methods. RESULTS: Among 123 heroin IDUs, 49 (39.8%) reported problematic prescription-type opioid use prior to heroin initiation ("prescription-type opioid first injection drug users" [PTO-First IDUs]). PTO-First IDUs had higher odds of injecting with friends (adjusted odds ratio [AOR] 6.01; 95% confidence interval [CI] 1.90-19.07), getting new syringes from a spouse/family member/sex partner (AOR 23.0; 95% CI 2.33-226.0), knowing about the local syringe exchange program (AOR 7.28; 95% CI 1.17-45.05), using powder cocaine (AOR 3.75; 95% CI 1.43-9.86), and perceiving themselves as less likely than other IDUs to get HIV (AOR 4.32; 95% CI 1.26-14.77). They had lower odds of ever being tested for HIV (AOR 0.25; 95% CI 0.08-0.80). CONCLUSION: A high proportion of young heroin IDUs reported problematic prescription-type opioid use prior to initiating heroin use. Our study provides several avenues for future investigation to help further characterize this subset of IDUs and their risks and perceptions related to HIV and other blood-borne pathogens.

Similar articles

See all similar articles

Cited by 51 articles

See all "Cited by" articles

References

    1. Substance Abuse and Mental Health Services Administration Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856) Rockville, MD: Available at: http://oas.samhsa.gov/NSDUH/2k9NSDUH/2k9Results.htm#Ch2Accessed July 23, 2011
    1. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey results on drug use, 1975–2010. Volume I: Secondary school students Ann Arbor, MI: Institute for Social Research, The University of Michigan; Available at: http://www.monitoringthefuture.orgAccessed July 23, 2011
    1. Substance Abuse and Mental Health Services Administration Substance Abuse and Mental Health Data Archive: Quick Tables for the Treatment Episode Data Set – Admissions (TEDS-A) – Concatenated, 1992 to present Available at: http://www.icpsr.umich.edu/quicktables/quickconfg.do?25221-20001Accessed July 23, 2011
    1. Substance Abuse and Mental Health Services Administration Detailed Tables: National Estimates, Drug-Related Emergency Department Visits for 2004–2009 Available at: http://dawninfo.samhsa.gov/data/Accessed July 23, 2011
    1. Centers for Disease Control and Prevention QuickStats: number of poisoning deaths involving opioid analgesics and other drugs or substances – United States, 1999–2007 Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5932a6.htm?s_cid=mm5932a6_eAccessed September 12, 2011

LinkOut - more resources

Feedback